Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 1, 1996, Pages 81-85

  Malin, David H ^a,c   Lake, J Ronald ^a   Payne, Mary C ^a   Short, Paul E ^a   Carter, Victoria A ^a   Cunningham, J Scott ^a   Wilson, Owen B ^b  

^a UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UH CL Box 237 ^*  (United States)

Author keywords

Endogenous opioid peptides; Naloxone; Nicotine; Nicotine abstinence; Nicotine dependence; Nicotine withdrawal; Opiate antagonists; Opiates

Indexed keywords

NALOXONE; NICOTINE; OPIATE PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG DEPENDENCE; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ANIMALIA; RODENTIA;

EID: 0029919321     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)00202-2     Document Type: Article

References (28)

1. Amir, S.; Amit, Z. Endogenous opioid ligands may mediate stress-induced changes in the affective properties of pain related behavior in rats. Life Sci. 23:1143-1152; 1978.
2. Bodnar, R. J.; Kelly, D. D.; Spiaggia, A.; Ehrenberg, C.; Glusman, M. Dose-dependent reductions by naloxone of analgesia induced by cold-water stress. Pharmacol. Biochem. Behav. 8: 667-672; 1978.
3. Conte-Devolx, B.; Oliver, C.; Giraud, P.; Gillioz, P.; Castanas, E.; Lissitsky, J. C.; Boudouresque, F.; Millet, Y. Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life Sci. 28:1067-1073; 1981.
4. Davenport, K. E.; Houdi, A. A.; VanLoon, G. R. Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: Evidence for nicotine-induced release of endogenous opioid. Neurosci. Lett. 113:40-46; 1990.
5. Flores, C. M.; Hulihan-Giblin, B. A.; Hornby, P. J.; Lumpkin, M. D.; Kellar, K. J. Partial Characterization of a neurotransmitter pathway regulating the in vivo release of prolactin. Neuroendocrinology 55:519-528; 1992.
6. Flores, C. M.; Hulihan-Giblin, B. A.; Kellar, K. J. Naltrexone blocks nicotine-induced prolactin release. Neuropharmacology 28:1287-1290; 1989.
7. Gianutsos, G.; Drawbaugh, R.; Hynes, M.; Lal, H. The narcotic withdrawal syndrome in the rat. In: Ehrenpreis, S.; Neidle, A., eds. Methods in narcotic research. New York: Marcel Dekker; 1975:293-309.
8. Gilbert, D. G.; Meliska, C. J.; Williams, C. L.; Jensen, R. A. Subjective correlates of cigarette-induced elevations of beta-endorphin and cortisol. Psychopharmacology 106:275-281; 1992.
9. Gorelick, D. A.; Rose, J.; Jarvik, M. E. Effect of naloxone on cigarette smoking. J. Subst. Abuse 1:153-159; 1989.
10. Gossop, M.; Powell, J.; Grey, S.; Hajek, P. What do opiate addicts and cigarette smokers mean by "craving"? A pilot study. Drug Alcohol Depend. 26:85-87; 1990.
11. Hexum, T. D.; Russett, L. R. Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig. Brain Res. 406:370-372; 1987.
12. Hodson, C. A.; Davenport, A.; Price, G.; Burden, H. W. Naltrexone treatment attenuates the inhibitory effect of nicotine on serum LH in rats. Life Sci. 53:839-846; 1993.
13. Houdi, A. A.; Pierzchala, K.; Marson, L.; Palkovits, M.; Van Loon, G. R. Nicotine-induced alteration in Tyr-Gly Gly and Metenkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides 12:161-166; 1991.
14. Jensen, R. A.; Gilbert, D. G.; Meliska, C. J.; Landrum, T. A. Characterization of a dose-response curve for nicotine-induced conditioned taste aversion in rats: Relationship to elevation of plasma β-endorphin concentration. Behav. Neural Biol. 53:428-440; 1990.
15. Karras, A.; Kane, J. M. Naloxone reduces cigarette smoking. Life Sci. 27:1541-1545; 1980.
16. Koob, G. F.; Maldonado, R.; Stinus, L. Neural substrates of opiate withdrawal. Trends Neurosci. 15:186-191; 1992.
17. Lewis, J. W.; Cannon, J. T.; Liebeskind, J. C. Opioid and non-opioid mechanisms of stress analgesia. Science 208:623-625; 1980.
18. Malin, D. H.; Lake, J. R.; Carter, V. A.; Cunningham, J. S.; Wilson, O. B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112:339-342; 1993.
19. Malin, D. H.; Lake, J. R.; Carter, V. A.; Cunningham, J. S.; Wilson, O. B. The nicotine antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 115:180-184; 1994.
20. Malin, D. H.; Lake, J. R.; Newlin-Maultsby, P.; Roberts, L. K.; Lanier, J. G.; Carter, V. A.; Cunningham, J. S.; Wilson, O. B. A rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 43:779-784; 1992.
21. Malin, D. H.; Murray, J. B.; Crucian, G. P.; Schweitzer, F. C.; Cook, R. E.; Skolnick, M. H. Auricular microelectrostimulation: Naloxone reversible attenuation of opiate abstinence syndrome. Biol. Psychiatry 24:886-890; 1988.
22. Nemeth-Coslett, R.; Griffiths, R. R. Naloxone does not affect cigarette smoking. Psychopharmacology 89:261-264; 1986.
23. Pierzchala, K.; Houdi, A. A.; VanLoon, G. R. Nicotine-induced alterations in brain regional concentrations of native and cryptic met- and leu-enkephalin. Peptides 8:1035-1043; 1987.
24. Pomerleau, O. F. Nicotine and the central nervous system: Biobehavioral effects of cigarette smoking. Am. J. Med. 93:2-8; 1992.
25. Pomerleau, O. F.; Fertig, J. B.; Seyler, E.; Jaffe, J. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81: 61-67; 1983.
26. Rosecrans, J. A.; Hendry, J. S.; Hong, J. S. Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse. Pharmacol. Biochem. Behav. 23: 141-143; 1985.
27. Seckl, J. R.; Johnson, M.; Shakespear, C.; Lightman, S. L. Endogenous opioids inhibit oxytocin release during nicotine-stimulated secretion of vasopressin in man. Clin. Endocrinol. 28:509-514; 1988.
28. Tobin, M. J.; Jenouri, G.; Sackner, M. A. Effect of naloxone on change in breathing pattern with smoking. Chest 82:530-537; 1982.